Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 71 Carcinoma, Non-Small-Cell Lung 69 Multiple Myeloma 55 Prostatic Neoplasms 54 Colorectal Neoplasms 42 Leukemia, Myeloid, Acute 39 Neoplasms 38 Melanoma 34 Lymphoma 33 Ovarian Neoplasms 30 Lymphoma, Non-Hodgkin 29 Lung Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 27 Sarcoma 27 Neoplasm Metastasis 25 Carcinoma, Hepatocellular 24 Pancreatic Neoplasms 23 Endometrial Neoplasms 23 Glioma 22 Carcinoma, Renal Cell 22 Lymphoma, Large B-Cell, Diffuse 21 Hodgkin Disease 21 Recurrence 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Head and Neck Neoplasms 20 Urinary Bladder Neoplasms 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Myelodysplastic Syndromes 18 Esophageal Neoplasms 17 Hematologic Neoplasms 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoadjuvant Immunotherapy × 30 days × Clear all

NCT07205497 2026-05-15

QNACTH

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Active not recruiting

Neoadjuvant Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡